HPV16-E7 Expression in Squamous Epithelium Creates a Local Immune Suppressive Environment via CCL2- and CCL5- Mediated Recruitment of Mast Cells

RS Woods, 2014, Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review, World J Clin Cases, 2, 172, 10.12998/wjcc.v2.i6.172

IH Frazer, 2011, Prevention and treatment of papillomavirus-related cancers through immunization, Annu Rev Immunol, 29, 111, 10.1146/annurev-immunol-031210-101308

SJ Galli, 2012, IgE and mast cells in allergic disease, Nat Med, 18, 693, 10.1038/nm.2755

BA Sayed, 2008, The master switch: the role of mast cells in autoimmunity and tolerance, Annu Rev Immunol, 26, 705, 10.1146/annurev.immunol.26.021607.090320

A Kobayashi, 2004, Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection, Cancer Res, 64, 6766, 10.1158/0008-5472.CAN-04-1091

AS Bergot, 2011, New Approaches to Immunotherapy for HPV Associated Cancers, Cancers (Basel), 3, 3461, 10.3390/cancers3033461

N Munoz, 2003, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N Engl J Med, 348, 518, 10.1056/NEJMoa021641

A Choyce, 2013, Expression of a single, viral oncoprotein in skin epithelium is sufficient to recruit lymphocytes, PloS one, 8, e57798, 10.1371/journal.pone.0057798

S Fiorenza, 2012, A combination of local inflammation and central memory T cells potentiates immunotherapy in the skin, J Immunol, 189, 5622, 10.4049/jimmunol.1200709

SR Mattarollo, 2011, NKT cells inhibit antigen-specific effector CD8 T cell induction to skin viral proteins, J Immunol, 187, 1601, 10.4049/jimmunol.1100756

A Rahimpour, 2012, gammadelta T cells augment rejection of skin grafts by enhancing cross-priming of CD8 T cells to skin-derived antigen, J Invest Dermatol, 132, 1656, 10.1038/jid.2012.16

SR Mattarollo, 2010, Invariant NKT cells in hyperplastic skin induce a local immune suppressive environment by IFN-gamma production, J Immunol, 184, 1242, 10.4049/jimmunol.0902191

CY Chan, 2013, Mast cell interleukin-10 drives localized tolerance in chronic bladder infection, Immunity, 38, 349, 10.1016/j.immuni.2012.10.019

SJ Galli, 2008, Immunomodulatory mast cells: negative, as well as positive, regulators of immunity, Nat Rev Immunol, 8, 478, 10.1038/nri2327

MA Grimbaldeston, 2007, Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B, Nat Immunol, 8, 1095, 10.1038/ni1503

DB Leveson-Gower, 2013, Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+ regulatory T cells, Blood, 122, 3659, 10.1182/blood-2013-08-519157

LM Coussens, 1999, Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis, Genes Dev, 13, 1382, 10.1101/gad.13.11.1382

S Balsitis, 2005, Examination of the pRb-dependent and pRb-independent functions of E7 in vivo, J Virol, 79, 11392, 10.1128/JVI.79.17.11392-11402.2005

N Kambe, 2001, Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes, Blood, 97, 2045, 10.1182/blood.V97.7.2045

A Shamloo, 2013, Complex chemoattractive and chemorepellent Kit signals revealed by direct imaging of murine mast cells in microfluidic gradient chambers, Integr Biol (Camb), 5, 1076, 10.1039/c3ib40025e

MA Grimbaldeston, 2005, Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo, Am J Pathol, 167, 835, 10.1016/S0002-9440(10)62055-X

PA Nigrovic, 2008, Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy, Am J Pathol, 173, 1693, 10.2353/ajpath.2008.080407

Schafer B, Piliponsky AM, Oka T, Song CH, Gerard NP, et al. (2013) Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice. J Allergy Clin Immunol 131: 541–548 e541–549.

A Dudeck, 2011, Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens, Immunity, 34, 973, 10.1016/j.immuni.2011.03.028

M Maurer, 2004, Mast cells promote homeostasis by limiting endothelin-1-induced toxicity, Nature, 432, 512, 10.1038/nature03085

K Khazaie, 2011, The significant role of mast cells in cancer, Cancer Metastasis Rev, 30, 45, 10.1007/s10555-011-9286-z

M Boerma, 2007, Influence of mast cells on outcome after heterotopic cardiac transplantation in rats, Transpl Int, 20, 256, 10.1111/j.1432-2277.2006.00420.x

VC de Vries, 2011, Mast cells condition dendritic cells to mediate allograft tolerance, Immunity, 35, 550, 10.1016/j.immuni.2011.09.012

LF Lu, 2006, Mast cells are essential intermediaries in regulatory T-cell tolerance, Nature, 442, 997, 10.1038/nature05010

P Andreu, 2010, FcRgamma activation regulates inflammation-associated squamous carcinogenesis, Cancer Cell, 17, 121, 10.1016/j.ccr.2009.12.019

T Tran, 2011, Loss of the alpha2beta1 integrin alters human papilloma virus-induced squamous carcinoma progression in vivo and in vitro, PLoS One, 6, e26858, 10.1371/journal.pone.0026858

I Halova, 2012, Mast cell chemotaxis - chemoattractants and signaling pathways, Front Immunol, 3, 119, 10.3389/fimmu.2012.00119

B Huang, 2008, SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment, Blood, 112, 1269, 10.1182/blood-2008-03-147033

Y Okayama, 2006, Development, migration, and survival of mast cells, Immunol Res, 34, 97, 10.1385/IR:34:2:97

CC Chen, 2005, Identification of mast cell progenitors in adult mice, Proc Natl Acad Sci U S A, 102, 11408, 10.1073/pnas.0504197102

LM Coussens, 1996, Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice, Am J Pathol, 149, 1899

B Ruffell, 2013, Cathepsin C is a tissue-specific regulator of squamous carcinogenesis, Genes Dev, 27, 2086, 10.1101/gad.224899.113

AM Piliponsky, 2010, Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice, Am J Pathol, 176, 926, 10.2353/ajpath.2010.090342

JO Lee, 1998, Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7, Nature, 391, 859, 10.1038/36038

SR Mattarollo, 2010, Secretion of IFN-gamma but not IL-17 by CD1d-restricted NKT cells enhances rejection of skin grafts expressing epithelial cell-derived antigen, J Immunol, 184, 5663, 10.4049/jimmunol.0903730

TM Danoff, 1994, Cloning, genomic organization, and chromosomal localization of the Scya5 gene encoding the murine chemokine RANTES, J Immunol, 152, 1182, 10.4049/jimmunol.152.3.1182

K Kleine-Lowinski, 2003, Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells, Int J Cancer, 107, 407, 10.1002/ijc.11411

A Cirilli, 2004, Targeting endothelin receptor type A in human cervical carcinoma cells, J Cardiovasc Pharmacol, 44, S72, 10.1097/01.fjc.0000166210.19921.2a

A Bagnato, 2011, Role of the endothelin axis and its antagonists in the treatment of cancer, Br J Pharmacol, 163, 220, 10.1111/j.1476-5381.2011.01217.x

PH Hart, 1998, Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice, J Exp Med, 187, 2045, 10.1084/jem.187.12.2045

VC de Vries, 2010, Mast cell protease 6 is required for allograft tolerance, Transplant Proc, 42, 2759, 10.1016/j.transproceed.2010.05.168

SJ Galli, 2005, Mast cells as “tunable” effector and immunoregulatory cells: recent advances, Annu Rev Immunol, 23, 749, 10.1146/annurev.immunol.21.120601.141025

DK Dalton, 2012, The roles of mast cells in anticancer immunity, Cancer Immunol Immunother, 61, 1511, 10.1007/s00262-012-1246-0

P Pittoni, 2011, Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers, Cancer Res, 71, 5987, 10.1158/0008-5472.CAN-11-1637

M Wilk, 2010, Intensity of angiogenesis and mast cell infiltration in cervical intraepithelial and invasive lesions - are they correlated, Pathol Res Pract, 206, 217, 10.1016/j.prp.2009.10.005

K Hodges, 2012, Mast cells, disease and gastrointestinal cancer: A comprehensive review of recent findings, Transl Gastrointest Cancer, 1, 138

T Tanaka, 2013, Mast cells and inflammation-associated colorectal carcinogenesis, Semin Immunopathol, 35, 245, 10.1007/s00281-012-0343-7

MJ Strouch, 2010, Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression, Clin Cancer Res, 16, 2257, 10.1158/1078-0432.CCR-09-1230

MA Grimbaldeston, 2003, The effect of ultraviolet radiation exposure on the prevalence of mast cells in human skin, The British journal of dermatology, 148, 300, 10.1046/j.1365-2133.2003.05113.x

TJ Kemp, 2011, HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection, Vaccine, 29, 2011, 10.1016/j.vaccine.2011.01.001

LL Villa, 2006, High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up, Br J Cancer, 95, 1459, 10.1038/sj.bjc.6603469

SE Vinzon, 2014, Protective Vaccination against Papillomavirus-Induced Skin Tumors under Immunocompetent and Immunosuppressive Conditions: A Preclinical Study Using a Natural Outbred Animal Model, PLoS Pathog, 10, e1003924, 10.1371/journal.ppat.1003924

IH Frazer, 2004, Prevention of cervical cancer through papillomavirus vaccination, Nat Rev Immunol, 4, 46, 10.1038/nri1260

CL Trimble, 2009, Development of therapeutic HPV vaccines, Lancet Oncol, 10, 975, 10.1016/S1470-2045(09)70227-X

PM O'Brien, 2002, Evasion of host immunity directed by papillomavirus-encoded proteins, Virus Res, 88, 103, 10.1016/S0168-1702(02)00123-5

ZG Fridlender, 2010, CCL2 blockade augments cancer immunotherapy, Cancer Res, 70, 109, 10.1158/0008-5472.CAN-09-2326

BZ Qian, 2011, CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis, Nature, 475, 222, 10.1038/nature10138

B Huang, 2007, CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers, Cancer Lett, 252, 86, 10.1016/j.canlet.2006.12.012

Yip KH, Kolesnikoff N, Yu C, Hauschild N, Taing H, et al. (2014) Mechanisms of vitamin D(3) metabolite repression of IgE-dependent mast cell activation. J Allergy Clin Immunol 133: 1356–1364, 1364 e1351–1314.